FDA Inspection 1164828 — Michael P. Husseman, MD
The FDA completed an inspection of Michael P. Husseman, MD on Feb 18, 2022 in Layton, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 18, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Layton, UT (United States)
Additional Details
Clinical Investigator (CI)